Peter

Karl Deisseroth, along with Peter Hegemann and Ernst Nagel, has been awarded the Nobel Prize in Physiology or Medicine for their work on optogenetics, a technique that uses light to control brain cells. The Science Media Centre España highlighted the award, and the news is drawing attention across several countries.

The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for their work on optogenetics, a technique that uses light to control the activity of nerve cells. The method, built on light-sensitive proteins found in algae, has transformed neuroscience by allowing researchers to switch specific neurons on and off in living animals, reshaping the study of the brain and potential treatments for neurological disorders.

Peter Watts' 2006 hard science fiction novel Blindsight is being discussed, with readers revisiting its ideas about consciousness, first contact and intelligence. The book follows a crew sent to investigate an alien presence at the edge of the solar system, and is widely regarded as one of the most thought-provoking first-contact novels of recent decades.

A theatregoer returned to see Romeo & Juliet at the New Vic theatre in Newcastle-under-Lyme for a second time, saying the production was just as fantastic as when first seen two weeks earlier. They described it as brilliant and were left humming Peter Gabriel's The Book of Love on the way home, suggesting a strong musical element in the show.

Broadway star Bernadette Peters brought her celebrated voice to the Granada Theatre in Santa Barbara, California, in a concert appearance covered by the Santa Barbara Independent. Peters, known for decades of acclaimed stage work, performed selections showcasing her signature range for local audiences.

The Nobel Prize in Physiology or Medicine was awarded Monday to American psychiatrist and neurologist Karl Deisseroth and German scientists Peter Hegemann and Georg Nagel for their pioneering work on optogenetics. The technique allows scientists to control neurons with light, transforming research into how the brain works and opening new paths for studying neurological and psychiatric disorders.

Peter Hegemann, a biophysicist at Humboldt University of Berlin whose research on light-sensing proteins has been supported by European Research Council grants, has been awarded a share of the Nobel Prize in Medicine. He is recognised for his work on optogenetics, the technique allowing nerve cells to be controlled with light, alongside his collaborators in the field. The award is being highlighted as a success for European research funding.

Posts circulating online quote a verse from 2 Peter: 'The Lord is not slow to do what he promised... Instead, he is patient for your sakes, not wanting anyone to perish.' The messages, decorated with hearts, crosses, angels and clocks, encourage readers not to forget the reminder that God's timing reflects patience rather than delay. They address 'dear friends' in a tone of personal religious encouragement.